Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS
· Delayed Price · Currency is USD
28.71
0.00 (0.00%)
At close: Mar 20, 2025
Swedish Orphan Biovitrum AB Employees
Swedish Orphan Biovitrum AB had 1,840 employees as of December 31, 2024. The number of employees increased by 68 or 3.84% compared to the previous year.
Employees
1,840
Change (1Y)
68
Growth (1Y)
3.84%
Revenue / Employee
$1,278,096
Profits / Employee
$190,779
Market Cap
9.83B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Swedish Orphan Biovitrum AB News
- 7 weeks ago - Swedish Orphan Biovitrum targets high single-digit growth in 2025 amid robust pipeline advancements - Seeking Alpha
- 7 weeks ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Swedish Orphan Biovitrum AB (publ) 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire
- 5 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 months ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ) - PRNewsWire